....the first snippet
Mesoblast will receive up to US$150 million in upfront and milestone payments prior to product launch,
as well as further commercialisation milestone payments. These payments include commitments up to
US$45 million within the first year comprising US$15 million on signing, US$20 million on receiving
regulatory approval to begin a confirmatory Phase III trial in Europe, and US$10 million on certain clinical
and manufacturing outcomes. Cumulative milestone payments could exceed US$1 billion depending on
the final outcome of Phase III studies and patient adoption. Mesoblast will also receive tiered double digit
royalties on product sales
....the first snippetMesoblast will receive up to US$150 million...
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |